Role of FODMAPs in Patients With Irritable Bowel Syndrome.
Pasquale Mansueto, Aurelio Seidita, Alberto D'Alcamo...
https://pubmed.ncbi.nlm.nih.gov/25694210/Actively Recruiting
Led by University of Palermo · Updated on 2025-06-22
50
Participants Needed
2
Research Sites
130 weeks
Total Duration
Researchers are investigating non-celiac wheat sensitivity NCWS, a condition where symptoms are triggered by wheat ingestion without celiac disease or wheat allergy. The study aims to understand if ancient wheat varieties are better tolerated by patients than modern ones, and to identify wheat components like amylasetrypsin inhibitors ATIs that may cause symptoms. The research explores the immune responses involved and the impact of different wheat breeding methods on symptom development. The study involves testing total proteins from different wheat genotypes to measure inflammatory responses in immune cells from NCWS patients and healthy individuals. Two wheat types, one causing high and the other low inflammatory responses in lab tests, will be given to patients. Participants will receive wheat flour or placebo xylose three times daily for 15 days in a blinded and randomized manner to compare effects on symptoms. Participants will be monitored for immune responses through blood and rectal tissue samples, measuring inflammatory markers over about six months. Clinical symptoms will be assessed before and after wheat challenges. The study uses questionnaires and clinical evaluations to track symptom changes. This detailed approach aims to clarify wheats role in triggering NCWS symptoms and the differences between wheat types.
CONDITIONS
Response to Different Wheat Genotypes in Not-celiac Wheat Sensitivity
A
Antonio Carroccio, PhD
P
Pasquale Mansueto, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Palermo
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 15 days
Participants receive wheat flour or placebo three times per day for 15 days to evaluate their clinical response to different wheat genotypes.
Multiple visits during the treatment period
Duration - Approximately 6 months
Participants are monitored for clinical response and inflammatory markers over approximately 6 months.
Periodic visits for assessments during follow-up
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Pasquale Mansueto, Aurelio Seidita, Alberto D'Alcamo...
https://pubmed.ncbi.nlm.nih.gov/25694210/Antonio Carroccio, Alberto D'Alcamo, Pasquale Mansueto
https://pubmed.ncbi.nlm.nih.gov/25625764/Marc Veldhoen, David R Withers
https://pubmed.ncbi.nlm.nih.gov/21030634/Antonio Carroccio, Pasquale Mansueto, Giuseppe Iacono...
https://pubmed.ncbi.nlm.nih.gov/22825366/Antonio Carroccio, Giovambattista Rini, Pasquale Mansueto
https://pubmed.ncbi.nlm.nih.gov/24275240/Hergen Spits, Tom Cupedo
https://pubmed.ncbi.nlm.nih.gov/22224763/Antonio Carroccio, Maurizio Soresi, Alberto D'Alcamo...
https://pubmed.ncbi.nlm.nih.gov/25430806/Hergen Spits, James P Di Santo
https://pubmed.ncbi.nlm.nih.gov/21113163/University of Palermo
Lead Sponsor